Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 03 tags : Disease save search
Global Nanomedicine Markets, 2015-2020, 2020-2025F, 2030F - Focus on Nanoparticles, Nanoshells, Nanotubes, Nanodevices, Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics
Published: 2021-11-03 (Crawled : 23:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: -0.89%
NVS | News | $93.08 -0.13% 0.86% 1.2M
|
Health Technology
|
| O: -0.06%
H: 0.28%
C: 0.18%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
AMGN | $264.07 -0.59% -0.59% 2.2M
|
Health Technology
|
| O: 0.08%
H: 0.07%
C: -1.54%
disease infectious disease cardiology device cardio
InMed Pharmaceuticals Files PCT Patent Application for Treating Neurodegenerative Disease Using a Rare Cannabinoid
Published: 2021-11-03 (Crawled : 13:00) - biospace.com/
INM 4 | $0.3054 -2.48% 260K
|
Health Technology
|
| O: -0.65%
H: 1.32%
C: 1.32%
disease neurodegenerative application patent rare
Bristol Myers Squibb Data at ACR Convergence 2021 Illustrate Scientific Advances for Immune-Mediated Rheumatic Diseases
Published: 2021-11-03 (Crawled : 12:15) - biospace.com/
BMY | $47.84 -0.87% -0.02% 12M
|
Health Technology
|
| O: -0.46%
H: 0.0%
C: 0.0%
disease media
Biogen Announces Late Breakers and Additional New Data Presentations at the 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Meeting
Published: 2021-11-03 (Crawled : 12:15) - biospace.com/
BIIB | $192.13 -1.55% -1.57% 1.3M
|
Health Technology
|
| O: -0.21%
H: 3.05%
C: 2.97%
presentation disease alzheimer clinical trials trials trial alzheimer’s alzheimer's disease alzheimer's
Allena Pharmaceuticals Receives Fast Track Designation from FDA for the Development of ALLN-346 for Chronic Treatment of Hyperuricemia in Patients With Gout and Advanced Chronic Kidney Disease
Published: 2021-11-03 (Crawled : 12:15) - globenewswire.com
ALNA | $0.075 -12.0%
|
Health Technology
|
| O: 22.35%
H: 12.5%
C: -3.85%
disease treatment fda fast track fast track designation kidney designation
AVROBIO Receives Rare Pediatric Disease Designation from the U.S. FDA for AVR-RD-05, a Gene Therapy for Mucopolysaccharidosis Type II (MPSII) or Hunter Syndrome
Published: 2021-11-03 (Crawled : 12:00) - biospace.com/
AVRO | $1.225 -2.78% -2.86% 200K
|
Health Technology
|
| O: 2.99%
H: 0.0%
C: 0.0%
disease fda rare pediatric disease designation gene therapy therapy syndros designation rare avr-rd-05 rd-05 mps-ih
BridgeBio Pharma Announces Dosing of First Patient in Phase 1/2 Trial of Investigational Gene Therapy for Canavan Disease
Published: 2021-11-03 (Crawled : 12:00) - biospace.com/
BBIO | $24.98 -1.03% -1.04% 1.7M
|
Health Technology
|
| O: 0.2%
H: 0.0%
C: 0.0%
disease phase 1 gene therapy therapy trial phase 2
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.